Risk Factors for Esophageal Fistula Associated with Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer

Medicine (United States)

Volumn 95, Issue 20, 2016, Pages

  Tsushima, Takahiro ^a   Mizusawa, Junki ^b   Sudo, Kazuki ^c   Honma, Yoshitaka ^c   Kato, Ken ^c   Igaki, Hiroyasu ^c   Tsubosa, Yasuhiro ^a   Shinoda, Masayuki ^d   Nakamura, Kenichi ^b   Fukuda, Haruhiko ^b   Kitagawa, Yuko ^e  

^a SHIZUOKA CANCER CENTER   (Japan)

^b National Cancer Center   (United States)

^c National Cancer Center Hospital   (United States)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG DOSE COMPARISON; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; ESOPHAGUS STENOSIS; FEMALE; HUMAN; INOPERABLE CANCER; LOCALLY ADVANCED UNRESECTABLE ESOPHAGEAL CANCER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; COMPLICATION; ESOPHAGEAL FISTULA; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGEAL FISTULA; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84973548016     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003699     Document Type: Article

References (14)

1. Matsubara T, Ueda M, Kokudo N, et al. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg. 2001;25:279-284.
2. Ikeda K, Ishida K, Sato N, et al. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus. 2001;14:197-201.
3. Fujita H, Sueyoshi S, Tanaka T, et al. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg. 2005;29:25-30discussion 1.
4. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915-2921.
5. Ishida K, Ando N, Yamamoto S, et al. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: A Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol. 2004;34:615-619.
6. Ishikura S, Ohtsu A, Shirao K, et al. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG9908). Esophagus. 2005;2:133-137.
7. Shinoda M, Ando N, Kato K, et al. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 2015;106:407-412.
8. Fujita H. A history of surgery for locally-Advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective. Ann Thorac Cardiovasc Surg. 2013;19:409-415.
9. Gabrail NY, Harrison BR, Sunwoo YC. Chemo-irradiation induced aortoesophageal fistula. J Surg Oncol. 1991;48:213-215.
10. Sivaraman SK, Drummond R. Radiation-induced aortoesophageal fistula: An unusual case of massive upper gastrointestinal bleeding. J Emerg Med. 2002;23:175-178.
11. Taniguchi H, Yamazaki K, Boku N, et al. Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta. Int J Clin Oncol. 2011;16:359-365.
12. Won E, Ilson DH, Herrera J, et al. Can induction chemotherapy improve dysphagia in locally advanced esophageal/GEJ cancer? J Clin Oncol. 2014; 32(S):suppl; abstr 148.
13. Satake M, Tahara M, Mochizuki S, et al. Phase I/II trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) followed by concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. J Clin Oncol. 2013; 31:suppl; abstr 4074.
14. Ogilvie AL, Dronfield MW, Ferguson R, et al. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23:1060-1067.